-
Guidelines on what to say when advertising in the EU
18 July 2023
This information is relevant for practitioners uploading and setting out information on their practice websites and marketing materials. Practitioner advertising and other public material needs to comply with EU Nutrition and Health Claims Regulation (NHCR) and advertising guidelines as set by individual Member States.
-
UK law changes for COVID-19 mass vaccination
10 September 2020
Have your say on changes to UK medicines law planned to herald the greatest vaccination programme in British history
-
ANH News Beat (week 15/2024)
11 April 2024
Our weekly roundup of the latest natural and covid news from across the globe in one place. This week EU Nature Restoration Law in trouble; Attacks on Free Speech; WHO Pandemic Treaty update; Prostate cancer test not fit for purpose; ADHD & Autism diagnoses skyrocket, plus much more...
-
Natural News Roundup (week 06/2022)
10 February 2022
Vitamin C and cancer; Calls for harmonisation of botanicals in EU; When is the menopause, not the menopause?; Chronic disease increases dementia risk; Exercise & type 2 diabetes; Antibiotics increase cancer risk; Junk food marketing
-
ANH News Beat (week 28/2023)
12 July 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 22/2023)
31 May 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 31/2023)
03 August 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 6/2023)
09 February 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
News Alerts: Week 44, 2017
31 October 2017
ASA continues to target natural health industry; Scottish Government takes ‘bold action’ on obesity; Just how independent will EFSA’s rules make it?; Pharma’s focus on natural products continues